Please login to the form below

Not currently logged in
Email:
Password:

Vertex Pharmaceuticals

This page shows the latest Vertex Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

NHS England’s Simon Stevens - no Trump drug price rhetoric here

NHS England’s Simon Stevens - no Trump drug price rhetoric here

Commenting on the negotiations a Vertex Pharmaceuticals spokesperson said: “We can confirm that NHS England and Vertex had a constructive meeting on Wednesday 25 April. ... Both parties recognise there is still some way to go to reach an agreement and

Latest news

More from news
Approximately 3 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    The biggest movers in respiratory were Teva (26%) and Vertex Pharmaceuticals (23.7%). ... Vertex has two - with Kalydeco sitting alongside Orkambi in an impressive respiratory portfolio.”.

  • Deal Watch March 2017 Deal Watch March 2017

    Vertex paid $160m in cash to Concert Pharmaceuticals to purchase the assets of CTP-656, and could pay an additional $90m in milestones based on regulatory approval and reimbursement. ... 250. Concert Pharmaceuticals. Vertex Pharmaceuticals. Product

  • Using social data to see patients more clearly Using social data to see patients more clearly

    This kind of information would have thrilled executives at Vertex Pharmaceuticals, the makers of Orkambi - and worried their competitors.

  • Deal Watch October 2015 Deal Watch October 2015

    17, 200. CRISPR Therapeutics/ Vertex Pharmaceuticals. CRISPR-Cas9 gene editing technology for discovery of new treatments for genetic diseases incl sickle cell disease, CF. ... Collaboration, option to license. 339. Regeneron Pharmaceuticals/ Mitsubishi

  • Orphan indication? No easy access Orphan indication? No easy access

    a series of incentives (including protocol assistance, extended market exclusivity, changes to the fee structure for registration) for the development of pharmaceuticals with orphan designation. ... found. Governments also step in in some instances, for

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics